skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

37 Total results for product and free and sample content found

Scrip

Scrip Asia 100 Report Extract

26 Mar 2021

Scrip_Asia_100_Content_Tile

Access Asia Pharma Intelligence expertise and hear from Pharma journalists across Asia to reveal deep regional expertise with this sample of Scrip's Asia 100 Report.

Topic Business Strategies China Company Analysis Drug Development Landscape Market Intelligence

Scrip

Scrip Asia 100: Sponsorship Opportunities

16 Jul 2020

MS Scrip Asia 100 Sample Chapter Cover Image

The annual “Scrip Asia 100”, the highly anticipated financial performance ranking of pharma companies headquartered in the APAC region, is coming soon. Don’t miss your opportunity to position yourself as a leader in APAC pharma with a sponsorship in this indispensable publication.  

Topic Company Analysis Market Intelligence Outlook

Medtech Insight

Medtech Insight Company Review

20 Apr 2020

Medtech Insight Company Review

Now more than ever, staying on top of the shifting dynamics of the medtech market is critical. Medtech Insight takes you inside recent company results for your view into the health and market landscape of medtech as we enter an unprecedented era.

Topic Cardiovascular Company Analysis

Scrip

Amarin's Vascepa Momentum Builds Ahead Of Next Week's FDA AdComm

By Jessica Merrill 06 Nov 2019

Article

Sales of the triglyceride-lowering medicine soared to $112.4m in the third quarter even before a label expansion that depends on the outcome of a vital US FDA advisory committee meeting on 14 November.

Topic Business Strategies Company Analysis

Scrip

Second Spring? Coverage Expansion Fuels Big Pharma China Growth But '4+7' Impact Lingers

By Brian Yang 01 Nov 2019

Second_Spring_Coverage_Expansion

AstraZeneca, Novartis and Roche deliver north of 20% sales growth in China again, driven by expanded reimbursement coverage and new product launches, but some clouds are on the horizon over falling sales due to the impact of the expanding “4+7” centralized procurement scheme.

Topic Company Analysis

Scrip

A timeline of the Takeda/Shire merger

24 Sep 2019

A staple of consumer magazines and tabloid newspapers involves coverage of celebrity relationships – who has been seen together? Who is dating? Will they become a permanent item? And are they going to live happily ever after? Readers can’t seem to get enough of it. Interestingly, while maybe not so racy as the celebrity goings-on, pharma industry watchers are keen to follow company couplings. Talk of mergers and acquisitions, one of the ways that companies can build scale, always attracts attention.  

Topic Business Strategies Company Analysis

Meddevicetracker

Meddevicetracker: New Company Portfolio Feature

04 Sep 2019

Meddevicetracker: New Company Portfolio Feature

Meddevicetracker now gives you to the ability to find and follow partners or competitors and track their key activities. Quickly and easily identify new partners and keep tabs on your competition with the portfolio feature in Meddevicetracker.

Topic Business Strategies Company Analysis

Meddevicetracker

Introducing Meddevicetracker's Market Analysis Tool

02 Aug 2019

Introducing Meddevicetracker's Market Analysis Tool

Find and manipulate the essential medical devices and diagnostics market intelligence you rely on from Meddevicetracker’s Market Analysis Reports with Meddevicetracker’s new interactive Market Analysis tool. 

Topic Strategy Business Strategies Company Analysis

Medtech Insight

SOPHiA Buys In More Bioinformatics Know-How For Cancer Genomics

By Catherine Longworth 11 Jun 2019

SOPHiA Buys In More Bioinformatics Know-How For Cancer Genomics

In a move to accelerate adoption of its AI-driven genomics platform, SOPHiA Genetics has acquired Interactive Biosoftware, the French developer of Alamut, a clinical decision support software used in  genomic data interpretation.

Topic Company Analysis Digital Health Business Strategies

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: